Translational Control of Retroviral Unspliced mRNA

逆转录病毒未剪接 mRNA 的翻译控制

基本信息

  • 批准号:
    7544521
  • 负责人:
  • 金额:
    $ 19.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-02-03 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

Retroviruses vary widely in their ability to cause neoplastic transformation or immunodeficiency. In addition, retroviruses are used as a backbone for constructing nonpathogenic vectors for gene transfer applications. However, in all cases, retroviruses recruit host cell proteins to achieve cytoplasmic expression of their unspliced genome-length RNA. We have identified sequences adjacent to the 5' cap of spleen necrosis virus (SNV) that facilitate Rev/Rev responsive element (RRE)-independent expression of HIV-1 unspliced reporter RNA. The RU5 region of the SNV long terminal repeat functions as a distinct position- and orientation-dependent cap-dependent translational enhancer of intron-containing HIV-1 gag RNA as well as nonviral luciferase (luc) RNA. Designated the SNV post-transcriptional control element (PCE). polysome analyses indicate that its functional mechanism is to stimulate translation initiation, although the PCE is not an internal ribosome entry sequence. Recently, we identified PCE activity in the 5' RNA terminus of two divergent retroviruses and in a cellular protooncogene mRNA. Our novel hypothesis is that 5' PCEs are a feature shared among divergent retroviruses and selected cellular mRNAs to achieve efficient translation in the face of multiple barriers to efficient cytoplasmic expression. Combined results of site-directed mutagenesis, RNA affinity chromatography and MALDI-TOF mass spectroscopy have determined redundant stem-loop motifs are necessary for PCE activity and that the structural features of the PCE present unpaired nucleotides for interaction with RNA helicase A (RHA). Knockdown of endogenous RHA by RNA silencing eliminates PCE translation stimulation and demonstrates that RHA is necessary for PCE activity. Our findings have generated the following essential questions: i) What conserved motifs necessaryfor translation stimulation are shared among retroviral PCEs? ii) What residues in RHA are necessary for interaction with the PCE and with translation factors or auxiliary proteins that mediate PCE activity? iii)What step of translation is stimulated? The overall goal of this proposal is to characterize the biochemical mechanism of PCE-RHA translational enhancement. Three integrated Specific Aims for this proposal are:1) to define conserved features in PCEs among divergent retroviruses; 2) to define the domains of RNA helicase A necessary for PCE translational enhancement; and 3) to evaluate the function of the PCE-RHA interaction in translation initiation. Our results will illuminate a unique control mechanism of eukaryotic post-transcriptional gene expression and define virus-host interactions that are important for viral replication and progression to disease. Our new fundamental knowledge of translational control will define the process by which cellular mRNAs become committed to cytoplasmic expression and produce new strategies to optimize vector systems for diverse gene transfer applications.
逆转录病毒引起肿瘤转化或免疫缺陷的能力差异很大。此外,本发明还提供了一种方法, 逆转录病毒被用作构建用于基因转移应用的非致病性载体的骨架。 然而,在所有情况下,逆转录病毒募集宿主细胞蛋白质以实现它们的细胞质表达。 未剪接的基因组长度RNA。我们已经确定了邻近脾坏死5'帽的序列 促进HIV-1未剪接的Rev/Rev应答元件(RRE)非依赖性表达的病毒(SNV) 报告RNA。SNV长末端重复序列的RU 5区作为不同的位置发挥作用, 含有内含子的HIV-1 gag RNA的方向依赖性帽依赖性翻译增强子,以及 非病毒荧光素酶(luc)RNA。命名为SNV转录后控制元件(PCE)。多核糖 分析表明,其功能机制是刺激翻译起始,而PCE不是 内部核糖体进入序列。最近,我们鉴定了两个人的5' RNA末端的PCE活性, 趋异逆转录病毒和细胞原癌基因mRNA。我们的新假设是,5'PCE是一个 不同的逆转录病毒和选定的细胞mRNA之间共享的特征,以实现在不同的逆转录病毒中的有效翻译。 面对有效细胞质表达的多重障碍。站点定向的组合结果 突变、RNA亲和层析和MALDI-TOF质谱已确定冗余 茎-环基序是PCE活性所必需的,PCE的结构特征呈现不配对 与RNA解旋酶A(RHA)相互作用的核苷酸。通过RNA沉默敲低内源性RHA 消除了PCE翻译刺激,并证明RHA是PCE活性所必需的。我们 研究结果产生了以下基本问题:i)翻译所必需的保守基序是什么 刺激在逆转录病毒PCE之间共享?ii)RHA中的哪些残基是与 PCE与翻译因子或介导PCE活性的辅助蛋白的结合?(三)什么步骤 翻译是刺激的吗?本提案的总体目标是描述 PCE-RHA翻译增强。该提案的三个综合具体目标是:1)确定 不同逆转录病毒PCE中的保守特征; 2)定义RNA解旋酶A的结构域 PCE翻译增强所必需的;和3)评估PCE-RHA相互作用在 翻译起始我们的研究结果将阐明真核生物转录后调控的独特机制 基因表达,并确定病毒-宿主相互作用,这对病毒复制和进展很重要, 疾病我们对翻译控制的新的基础知识将定义细胞 mRNA致力于细胞质表达并产生新的策略来优化载体 用于多种基因转移应用的系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathleen A. Boris-Lawrie其他文献

Kathleen A. Boris-Lawrie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kathleen A. Boris-Lawrie', 18)}}的其他基金

HIV-1 cap epigenetic modification
HIV-1帽表观遗传修饰
  • 批准号:
    10866730
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Characterization of RHA:RT interactions in HIV-1 reverse transcription
HIV-1 逆转录中 RHA:RT 相互作用的表征
  • 批准号:
    10403061
  • 财政年份:
    2022
  • 资助金额:
    $ 19.31万
  • 项目类别:
Characterization of RHA:RT interactions in HIV-1 reverse transcription
HIV-1 逆转录中 RHA:RT 相互作用的表征
  • 批准号:
    10614580
  • 财政年份:
    2022
  • 资助金额:
    $ 19.31万
  • 项目类别:
The Center for HIV RNA Studies (CRNA)
HIV RNA 研究中心 (CRNA)
  • 批准号:
    8512891
  • 财政年份:
    2012
  • 资助金额:
    $ 19.31万
  • 项目类别:
Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
  • 批准号:
    7039375
  • 财政年份:
    2006
  • 资助金额:
    $ 19.31万
  • 项目类别:
Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
  • 批准号:
    7339629
  • 财政年份:
    2006
  • 资助金额:
    $ 19.31万
  • 项目类别:
Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
  • 批准号:
    7996196
  • 财政年份:
    2006
  • 资助金额:
    $ 19.31万
  • 项目类别:
Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
  • 批准号:
    7176238
  • 财政年份:
    2006
  • 资助金额:
    $ 19.31万
  • 项目类别:
Retrovirus Models of Cellular Post-transcriptional Gene Expression
细胞转录后基因表达的逆转录病毒模型
  • 批准号:
    8376222
  • 财政年份:
    2003
  • 资助金额:
    $ 19.31万
  • 项目类别:
Retrovirus Models of Cellular Post-transcriptional Gene Expression
细胞转录后基因表达的逆转录病毒模型
  • 批准号:
    8079529
  • 财政年份:
    2003
  • 资助金额:
    $ 19.31万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了